ARCHIVES

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

This article is from The Cancer Letter archive.

Vol. 38 No. 37 | October 5, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together

June 3, 1994

In Brief: Money Buys Progress In Cancer Research, DeVita says; John Montgomery To Give Clowes Lecture

April 29, 1983

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

February 4, 2005

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003